Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03466060 · ClinicalTrials.gov registry record · NA
Clinical Evaluation of 3 Contact Lens Materials With 3 Solution Types
A NA study, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 130
- Enrollment target
NCT03466060 is a NA study that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 130 participants.
The verdict
NCT03466060, a NA study, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 130 participants
- Enrollment target
Study Summary
This is a multi-site, randomized, double-masked, contralateral, 2 treatment x 2 period crossover, dispensing, five-visit study to gain clinical insights of the study lenses and solutions.
Interventions
- DEVICE Opti-Free : RevitaLens / Clear Care : RevitaLens
- DEVICE Opti-Free : RevitaLens / RevitaLens : Clear Care
- DEVICE Clear Care : RevitaLens/ Opti-Free : RevitaLens
- DEVICE Clear Care : RevitaLens / RevitaLens : Opti-Free
- DEVICE RevitaLens : Clear Care/ Opti-Free : RevitaLens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2018-02-07 |
| Est. Completion | 2018-06-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03466060
The ClinicalTrials.gov registry entry for NCT03466060 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Opti-Free : RevitaLens / Clear Care : RevitaLens is the first listed.
NCT03466060 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03466060 about?
NCT03466060 is a clinical study titled "Clinical Evaluation of 3 Contact Lens Materials With 3 Solution Types". This is a multi-site, randomized, double-masked, contralateral, 2 treatment x 2 period crossover, dispensing, five-visit study to gain clinical insights of the study lenses and solutions.
What is the current status of trial NCT03466060?
This trial is currently completed. It is a NA study. The enrollment target is 130 participants. The study started on 2018-02-07. Estimated completion is 2018-06-19.
What interventions are being tested in trial NCT03466060?
The interventions under investigation include: Opti-Free : RevitaLens / Clear Care : RevitaLens (DEVICE), Opti-Free : RevitaLens / RevitaLens : Clear Care (DEVICE), Clear Care : RevitaLens/ Opti-Free : RevitaLens (DEVICE), Clear Care : RevitaLens / RevitaLens : Opti-Free (DEVICE), RevitaLens : Clear Care/ Opti-Free : RevitaLens (DEVICE).
Who is sponsoring clinical trial NCT03466060?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.